- Home
- MGRX vs COSM Comparison
MGRX vs COSM Comparison
Compare MGRX & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGRX
- COSM
- Stock Information
- Founded
- MGRX 2021
- COSM 2009
- Country
- MGRX United States
- COSM Greece
- Employees
- MGRX N/A
- COSM N/A
- Industry
- MGRX Computer Software: Prepackaged Software
- COSM Other Pharmaceuticals
- Sector
- MGRX Technology
- COSM Health Care
- Exchange
- MGRX Nasdaq
- COSM Nasdaq
- Market Cap
- MGRX 8.1M
- COSM 8.2M
- IPO Year
- MGRX 2023
- COSM 2013
- Fundamental
- Price
- MGRX $1.38
- COSM $0.45
- Analyst Decision
- MGRX
- COSM
- Analyst Count
- MGRX 0
- COSM 0
- Target Price
- MGRX N/A
- COSM N/A
- AVG Volume (30 Days)
- MGRX 434.6K
- COSM 814.2K
- Earning Date
- MGRX 05-27-2025
- COSM 05-15-2025
- Dividend Yield
- MGRX N/A
- COSM N/A
- EPS Growth
- MGRX N/A
- COSM N/A
- EPS
- MGRX N/A
- COSM N/A
- Revenue
- MGRX $615,873.00
- COSM $54,426,402.00
- Revenue This Year
- MGRX N/A
- COSM $28.14
- Revenue Next Year
- MGRX N/A
- COSM N/A
- P/E Ratio
- MGRX N/A
- COSM N/A
- Revenue Growth
- MGRX N/A
- COSM 1.97
- 52 Week Low
- MGRX $1.49
- COSM $0.28
- 52 Week High
- MGRX $16.80
- COSM $1.58
- Technical
- Relative Strength Index (RSI)
- MGRX 32.29
- COSM 53.31
- Support Level
- MGRX $1.65
- COSM $0.40
- Resistance Level
- MGRX $1.84
- COSM $0.50
- Average True Range (ATR)
- MGRX 0.17
- COSM 0.06
- MACD
- MGRX 0.02
- COSM 0.01
- Stochastic Oscillator
- MGRX 4.62
- COSM 46.91
About MGRX Mangoceuticals Inc.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.